366
Views
43
CrossRef citations to date
0
Altmetric
Research Article

Immunologic profile of excessive body weight

, , , , , , , , , , & show all
Pages 243-251 | Received 03 Sep 2010, Accepted 10 Dec 2010, Published online: 20 Apr 2011

References

  • Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O’Brien WL, Bassett DR Jr, Schmitz KH, Emplaincourt PO, Jacobs DR Jr, Leon AS. (2000). Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498–S504.
  • Alberti KG, Zimmet PZ. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553.
  • Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G. (1995). Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 182:155–162.
  • Baik I, Ascherio A, Rimm EB, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC. (2000). Adiposity and mortality in men. Am J Epidemiol 152:264–271.
  • Balkwill FR, Burke F. (1989). The cytokine network. Immunol Today 10:299–304.
  • Barness LA, Opitz JM, Gilbert-Barness E. (2007). Obesity: genetic, molecular, and environmental aspects. Am J Med Genet a 143A:3016–3034.
  • Bigaard J, Tjønneland A, Thomsen BL, Overvad K, Heitmann BL, Sørensen TI. (2003). Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res 11:895–903.
  • Björntorp P. (1985). Regional patterns of fat distribution. Ann Intern Med 103:994–995.
  • Bracho-Riquelme RL, Reyes-Romero MA, Pescador N, Flores-García AI. (2008). A leptin serum concentration less than 10 ng/ml is a predictive marker of outcome in patients with moderate to severe secondary peritonitis. Eur Surg Res 41:238–244.
  • Branca F, Nikogosian H, Lobstein T. (2007) The Challenge of Obesity in the WHO European Region and the Strategies for Response. Copenhagen, Denmark: WHO.
  • Bray GA. (1989). Classification and evaluation of the obesities. Med Clin North Am 73:161–184.
  • Bruun JM, Pedersen SB, Richelsen B. (2000). Interleukin-8 production in human adipose tissue. inhibitory effects of anti-diabetic compounds, the thiazolidinedione ciglitazone and the biguanide metformin. Horm Metab Res 32:537–541.
  • Bruun JM, Pedersen SB, Richelsen B. (2001). Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J Clin Endocrinol Metab 86:1267–1273.
  • Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. (1999). Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097–1105.
  • Christine Friedenreich PF, Corinne Casagrande, Nadia Slimani, Bertrand Hemon, Elio Riboli. (2005). An Update on How to Treat Physical Activity Data in the Epic Study. EPIC.
  • Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292–295.
  • Crepaldi G, Belfiore F, Bosello O, Caviezel F, Contaldo F, Enzi G, Melchionda N. (1991). Italian Consensus Conference–overweight, obesity and health. Int J Obes 15:781–790.
  • Curat CA, Miranville A, Sengenès C, Diehl M, Tonus C, Busse R, Bouloumié A. (2004). From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53:1285–1292.
  • de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. (2003). Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 10:133–139.
  • Diehr P, Bild DE, Harris TB, Duxbury A, Siscovick D, Rossi M. (1998). Body mass index and mortality in nonsmoking older adults: the Cardiovascular Health Study. Am J Public Health 88:623–629.
  • Dolan CM, Kraemer H, Browner W, Ensrud K, Kelsey JL. (2007). Associations between body composition, anthropometry, and mortality in women aged 65 years and older. Am J Public Health 97:913–918.
  • Drake TA, Ping P. (2007). Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Proteomics approaches to the systems biology of cardiovascular diseases. J Lipid Res 48:1–8.
  • Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. (2002). IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168:3195–3204.
  • Durazo-Arvizu RA, McGee DL, Cooper RS, Liao Y, Luke A. (1998). Mortality and optimal body mass index in a sample of the US population. Am J Epidemiol 147:739–749.
  • Eckel RH, Krauss RM. (1998). American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 97:2099–2100.
  • Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ; Comparative Risk Assessment Collaborating Group. (2002). Selected major risk factors and global and regional burden of disease. Lancet 360:1347–1360.
  • Farber JM. (1997). Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61:246–257.
  • Fawcett T. (2006). An introduction to ROC analysis. Pattern Recognition Letters 27:861–874.
  • Fernandes JL, Mamoni RL, Orford JL, Garcia C, Selwyn AP, Coelho OR, Blotta MH. (2004). Increased Th1 activity in patients with coronary artery disease. Cytokine 26:131–137.
  • Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA. (2001). Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161:1581–1586.
  • Flier JS. (2004). Obesity wars: molecular progress confronts an expanding epidemic. Cell 116:337–350.
  • Folsom AR, Kaye SA, Sellers TA, Hong CP, Cerhan JR, Potter JD, Prineas RJ. (1993). Body fat distribution and 5-year risk of death in older women. Jama 269:483–487.
  • Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE, Hong CP, Sellers TA, Lazovich D, Prineas RJ. (2000). Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women’s Health Study. Arch Intern Med 160:2117–2128.
  • Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. (2000). Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 72:694–701.
  • García MC, Wernstedt I, Berndtsson A, Enge M, Bell M, Hultgren O, Horn M, Ahrén B, Enerback S, Ohlsson C, Wallenius V, Jansson JO. (2006). Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes 55:1205–1213.
  • Harris T, Cook EF, Garrison R, Higgins M, Kannel W, Goldman L. (1988). Body mass index and mortality among nonsmoking older persons. The Framingham Heart Study. Jama 259:1520–1524.
  • Herder C, Hauner H, Kempf K, Kolb H, Skurk T. (2007). Constitutive and regulated expression and secretion of interferon-gamma-inducible protein 10 (IP-10/CXCL10) in human adipocytes. Int J Obes (Lond) 31:403–410.
  • Hosnijeh FS, Krop EJ, Portengen L, Rabkin CS, Linseisen J, Vineis P, Vermeulen R. (2010a). Stability and reproducibility of simultaneously detected plasma and serum cytokine levels in asymptomatic subjects. Biomarkers 15:140–148.
  • Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE. (2004). Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 351:2694–2703.
  • Hubert HB, Feinleib M, McNamara PM, Castelli WP. (1983). Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67:968–977.
  • Chipman HA, George EI, McCulloch RE. (2008). BART: Bayesian Additive Regression Trees.
  • Chipman H, McCulloch R. (2009). BayesTree: Bayesian Methods for Tree Based Models. Implementation of BART: Bayesian Additive Regression Trees.
  • Hulthe J, Hultén LM, Fagerberg B. (2003). Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Metab Clin Exp 52:1612–1614.
  • Isidori AM, Strollo F, Morè M, Caprio M, Aversa A, Moretti C, Frajese G, Riondino G, Fabbri A. (2000). Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 85:1954–1962.
  • James PT, Leach R, Kalamara E, Shayeghi M. (2001). The worldwide obesity epidemic. Obes Res 9(Suppl 4):228S–233S.
  • Jensen DM, Damm P, Sørensen B, Mølsted-Pedersen L, Westergaard JG, Ovesen P, Beck-Nielsen H. (2003). Pregnancy outcome and prepregnancy body mass index in 2459 glucose-tolerant Danish women. Am J Obstet Gynecol 189:239–244.
  • Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. (1996). Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation 93:1372–1379.
  • Kahn HS, Austin H, Williamson DF, Arensberg D. (1996). Simple anthropometric indices associated with ischemic heart disease. J Clin Epidemiol 49:1017–1024.
  • Kalmijn S, Curb JD, Rodriguez BL, Yano K, Abbott RD. (1999). The association of body weight and anthropometry with mortality in elderly men: the Honolulu Heart Program. Int J Obes Relat Metab Disord 23:395–402.
  • Kannel WB, Cupples LA, Ramaswami R, Stokes J 3rd, Kreger BE, Higgins M. (1991). Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol 44:183–190.
  • Kannel WB, D’Agostino RB, Cobb JL. (1996). Effect of weight on cardiovascular disease. Am j Clin Nutr 63:419S–422S.
  • Katz DL, O’Connell M, Yeh MC, Nawaz H, Njike V, Anderson LM, Cory S, Dietz W; Task Force on Community Preventive Services. (2005). Public health strategies for preventing and controlling overweight and obesity in school and worksite settings: a report on recommendations of the Task Force on Community Preventive Services. mmwr Recomm Rep 54:1–12.
  • Katzmarzyk PT, Craig CL, Bouchard C. (2002). Adiposity, adipose tissue distribution and mortality rates in the Canada Fitness Survey follow-up study. Int J Obes Relat Metab Disord 26:1054–1059.
  • Kim CS, Park HS, Kawada T, Kim JH, Lim D, Hubbard NE, Kwon BS, Erickson KL, Yu R. (2006). Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond) 30:1347–1355.
  • Lahmann PH, Lissner L, Gullberg B, Berglund G. (2002). A prospective study of adiposity and all-cause mortality: the Malmö Diet and Cancer Study. Obes Res 10:361–369.
  • Lee IM, Manson JE, Hennekens CH, Paffenbarger RS Jr. (1993). Body weight and mortality. A 27-year follow-up of middle-aged men. Jama 270:2823–2828.
  • Lew EA, Garfinkel L. (1979). Variations in mortality by weight among 750,000 men and women. J Chronic Dis 32:563–576.
  • Linden A. (2006). Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis. J Eval Clin Pract 12:132–139.
  • Lindon JC, Holmes E, Nicholson JK. (2003). So what’s the deal with metabonomics? Anal Chem 75:384A–391A.
  • Lindsted K, Tonstad S, Kuzma JW. (1991). Body mass index and patterns of mortality among Seventh-day Adventist men. Int J Obes 15:397–406.
  • Luster AD, Unkeless JC, Ravetch JV. (1985). Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672–676.
  • Manica-Cattani MF, Bittencourt L, Rocha MI, Algarve TD, Bodanese LC, Rech R, Machado MM, Santos GF, Gottlieb MG, Schwanke CH, Piccoli JE, Duarte MF, Cruz IB. (2010). Association between interleukin-1 beta polymorphism (+3953) and obesity. Mol Cell Endocrinol 314:84–89.
  • Manson JE, Stampfer MJ, Hennekens CH, Willett WC. (1987). Body weight and longevity. A reassessment. Jama 257:353–358.
  • Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE. (1995). Body weight and mortality among women. N Engl J Med 333:677–685.
  • Marshall JA, Grunwald GK, Donahoo WT, Scarbro S, Shetterly SM. (2000). Percent body fat and lean mass explain the gender difference in leptin: analysis and interpretation of leptin in Hispanic and non-Hispanic white adults. Obes Res 8:543–552.
  • Meier CA, Chicheportiche R, Dreyer M, Dayer JM. (2003). IP-10, but not RANTES, is upregulated by leptin in monocytic cells. Cytokine 21:43–47.
  • Nedvídková J, Smitka K, Kopský V, Hainer V. (2005). Adiponectin, an adipocyte-derived protein. Physiol Res 54:133–140.
  • Pérez A, Ybarra Muñoz J, Blay Cortés V, de Pablos Velasco P. (2007). Obesity and cardiovascular disease. Public Health Nutr 10:1156–1163.
  • Pocernich M. (2010). Verification package for “R” - Forecast verification utilities.
  • Rajala MW, Scherer PE. (2003). Minireview: The adipocyte–at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765–3773.
  • Rao SV, Donahue M, Pi-Sunyer FX, Fuster V. (2001). Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity as a risk factor in coronary artery disease. Am Heart j 142:1102–1107.
  • Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, Willett WC, Manson JE. (1998). Abdominal adiposity and coronary heart disease in women. Jama 280:1843–1848.
  • Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondière UR, Hémon B, Casagrande C, Vignat J, Overvad K, Tjønneland A, Clavel-Chapelon F, Thiébaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, González CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R. (2002). European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113–1124.
  • Riboli E, Kaaks R. (1997). The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26(Suppl 1):S6–14.
  • Rimm EB, Stampfer MJ, Giovannucci E, Ascherio A, Spiegelman D, Colditz GA, Willett WC. (1995). Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 141:1117–1127.
  • Rothenbacher D, Müller-Scholze S, Herder C, Koenig W, Kolb H. (2006). Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler Thromb Vasc Biol 26:194–199.
  • Hosnijeh SF, Krop EJ, Scoccianti C, Krogh V, Palli D, Panico S, Tumino R, Sacredote C, Nawroly N, Portengen L, Linseisen J, Vineis P, Vermeulen R. (2010b). Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 19:1577–1584.
  • Sauer U, Heinemann M, Zamboni N. (2007). Genetics. Getting closer to the whole picture. Science 316:550–551.
  • Schroll M. (1981). A longitudinal epidemiological survey of relative weight at age 25,50 and 60 in the Glostrup population of men and women born in 1914. Dan Med Bull 28:106–116.
  • Seidell JC. (1997). Time trends in obesity: an epidemiological perspective. Horm Metab Res 29:155–158.
  • Seidell JC, Verschuren WM, van Leer EM, Kromhout D. (1996). Overweight, underweight, and mortality. A prospective study of 48,287 men and women. Arch Intern Med 156:958–963.
  • Shaper AG, Wannamethee SG, Walker M. (1997). Body weight: implications for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men. BMJ 314:1311–1317.
  • Shimada K, Miyauchi K, Mokuno H, Miyazaki T, Seki E, Watanabe Y, Iwama Y, Shigekiyo M, Matsumoto M, Okazaki S, Tanimoto K, Kawamura M, Suzuki H, Kurata T, Sato H, Daida H. (2002). Predictive value of the adipocyte-derived plasma protein adiponectin for restenosis after elective coronary stenting. Jpn Heart J 43:85–91.
  • Shinton R, Sagar G, Beevers G. (1995). Body fat and stroke: unmasking the hazards of overweight and obesity. J Epidemiol Community Health 49:259–264.
  • Simpson JA, MacInnis RJ, Peeters A, Hopper JL, Giles GG, English DR. (2007). A comparison of adiposity measures as predictors of all-cause mortality: the Melbourne Collaborative Cohort Study. Obesity (Silver Spring) 15:994–1003.
  • Singh PN, Lindsted KD. (1998). Body mass and 26-year risk of mortality from specific diseases among women who never smoked. Epidemiology 9:246–254.
  • Spataro JA, Dyer AR, Stamler J, Shekelle RB, Greenlund K, Garside D. (1996). Measures of adiposity and coronary heart disease mortality in the Chicago Western Electric Company Study. J Clin Epidemiol 49:849–857.
  • Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. (1998). The effect of age on the association between body-mass index and mortality. N Engl J Med 338:1–7.
  • Stevens J, Keil JE, Rust PF, Tyroler HA, Davis CE, Gazes PC. (1992). Body mass index and body girths as predictors of mortality in black and white women. Arch Intern Med 152:1257–1262.
  • Straczkowski M, Dzienis-Straczkowska S, Stêpieñ A, Kowalska I, Szelachowska M, Kinalska I. (2002). Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J Clin Endocrinol Metab 87:4602–4606.
  • Strandberg L, Lorentzon M, Hellqvist A, Nilsson S, Wallenius V, Ohlsson C, Jansson JO. (2006). Interleukin-1 system gene polymorphisms are associated with fat mass in young men. J Clin Endocrinol Metab 91:2749–2754.
  • Suk SH, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS, Paik MC; Northern Manhattan Stroke Study. (2003). Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 34:1586–1592.
  • Suzuki K, Inoue T, Yanagisawa A, Kimura A, Ito Y, Hamajima N. (2009). Association between Interleukin-1B C-31T polymorphism and obesity in Japanese. j Epidemiol 19:131–135.
  • Tegnér J, Skogsberg J, Björkegren J. (2007). Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Multi-organ whole-genome measurements and reverse engineering to uncover gene networks underlying complex traits. J Lipid Res 48:267–277.
  • Troiano RP, Frongillo EA Jr, Sobal J, Levitsky DA. (1996). The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int J Obes Relat Metab Disord 20:63–75.
  • Tuomilehto J, Salonen JT, Marti B, Jalkanen L, Puska P, Nissinen A, Wolf E. (1987). Body weight and risk of myocardial infarction and death in the adult population of eastern Finland. Br Med J (Clin Res Ed) 295:623–627.
  • Vandenbroucke JP, Mauritz BJ, de Bruin A, Verheesen JH, van der Heide-Wessel C, van der Heide RM. (1984). Weight, smoking, and mortality. Jama 252:2859–2860.
  • Visscher TL, Seidell JC, Molarius A, van der Kuip D, Hofman A, Witteman JC. (2001). A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study. Int J Obes Relat Metab Disord 25:1730–1735.
  • Walker SP, Rimm EB, Ascherio A, Kawachi I, Stampfer MJ, Willett WC. (1996). Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol 144:1143–1150.
  • Watson AD. (2006). Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res 47:2101–2111.
  • Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–1808.
  • Weiss JN, Yang L, Qu Z. (2006). Systems biology approaches to metabolic and cardiovascular disorders: network perspectives of cardiovascular metabolism. J Lipid Res 47:2355–2366.
  • Wellen KE, Hotamisligil GS. (2005). Inflammation, stress, and diabetes. j Clin Invest 115:1111–1119.
  • Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R; Prospective Studies Collaboration. (2009). Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373:1083–1096.
  • WHO. (2000). Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894:1–253.
  • Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, Hennekens CH. (1995). Weight, weight change, and coronary heart disease in women. Risk within the ‘normal’ weight range. Jama 273:461–465.
  • Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. (2002). Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162:1867–1872.
  • Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. (2004). Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323:630–635.
  • Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821–1830.
  • Yuan JM, Ross RK, Gao YT, Yu MC. (1998). Body weight and mortality: a prospective evaluation in a cohort of middle-aged men in Shanghai, China. Int J Epidemiol 27:824–832.
  • Zhang X, Shu XO, Yang G, Li H, Cai H, Gao YT, Zheng W. (2007). Abdominal adiposity and mortality in Chinese women. Arch Intern Med 167:886–892.
  • Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432.
  • Zhou B, Wu Y, Yang J, Li Y, Zhang H, Zhao L. (2002). Overweight is an independent risk factor for cardiovascular disease in Chinese populations. Obes Rev 3:147–156.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.